Autologous T-cell therapy targeting multiple antigens shows promise treating pancreatic cancer
January 12, 2026
January 12, 2026
HOUSTON, Texas, Jan. 12 -- The Baylor College of Medicine posted the following news:
* * *
Autologous T-cell therapy targeting multiple antigens shows promise treating pancreatic cancer
*
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a first in-human phase 1/2 trial. The TACTOPS trial, which investigated the safety and clinical effects of autologous T cell . . .
* * *
Autologous T-cell therapy targeting multiple antigens shows promise treating pancreatic cancer
*
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a first in-human phase 1/2 trial. The TACTOPS trial, which investigated the safety and clinical effects of autologous T cell . . .